Oral Disease-Modifying Therapies for Multiple Sclerosis: Are We There Yet?

被引：3
|
作者：
Vijayshree Yadav
Dennis Bourdette
机构：
[1] Oregon Health & Science University,Department of Neurology
来源：
Current Neurology and Neuroscience Reports | 2010年 / 10卷 / 5期
关键词：
Multiple Sclerosis; Natalizumab; Glatiramer Acetate; Fingolimod; Cladribine;
D O I：
10.1007/s11910-010-0126-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：333 / 335
页数：2
相关论文
共 50 条
  • [1] Oral Disease-Modifying Therapies for Multiple Sclerosis
    Kim, Woojun
    Zandona, Manuella Edler
    Kim, Su-Hyun
    Kim, Ho Jin
    [J]. JOURNAL OF CLINICAL NEUROLOGY, 2015, 11 (01): : 9 - 19
  • [2] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Kretzschmar, Benedikt
    Pellkofer, Hannah
    Weber, Martin S.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (04)
  • [3] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Benedikt Kretzschmar
    Hannah Pellkofer
    Martin S. Weber
    [J]. Current Neurology and Neuroscience Reports, 2016, 16
  • [4] Emerging disease-modifying oral therapies for multiple sclerosis
    Losy, Jacek
    Kalinowska-Lyszczarz, Alicja
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2011, 231 (1-2) : 15 - 22
  • [5] PERSISTENCE TO ORAL AND INJECTABLE MULTIPLE SCLEROSIS DISEASE-MODIFYING THERAPIES
    Galaznik, A.
    Rusli, E.
    Lempernesse, B.
    Shilnikova, A.
    Ransom, J.
    Berger, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S287 - S287
  • [6] Persistence to oral disease-modifying therapies in multiple sclerosis patients
    Simona Lattanzi
    Maura Danni
    Ruja Taffi
    Raffaella Cerqua
    Giulia Carlini
    Alessandra Pulcini
    Leandro Provinciali
    Mauro Silvestrini
    [J]. Journal of Neurology, 2017, 264 : 2325 - 2329
  • [7] Persistence to oral disease-modifying therapies in multiple sclerosis patients
    Lattanzi, Simona
    Danni, Maura
    Taffi, Ruja
    Cerqua, Raffaella
    Carlini, Giulia
    Pulcini, Alessandra
    Provinciali, Leandro
    Silvestrini, Mauro
    [J]. JOURNAL OF NEUROLOGY, 2017, 264 (11) : 2325 - 2329
  • [8] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [9] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    [J]. NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [10] Disease-modifying therapies for multiple sclerosis
    John R. Corboy
    Douglas S. Goodin
    Elliot M. Frohman
    [J]. Current Treatment Options in Neurology, 2003, 5 (1) : 35 - 54
12345